| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Departments of Pathology, 2 Physiology, 3 Pediatrics, and 4 Preventive Medicine, University of Tennessee, Memphis, Tennessee 38163
The lipid mediator lysophosphatidic acid (LPA) regulates cell proliferation and enhances cell motility in vitro, both of which are important events in wound healing. To evaluate the effects of LPA in vivo, it was applied to a full-thickness wound of rat skin. LPA in micromolar concentrations, or solvent, was applied daily. Animals were killed at 1, 3, 6, and 9 days after wounding and processed for histological evaluation, including hematoxylin-eosin staining and histochemical markers for macrophage-histiocytes, proliferating cells, and capillary endothelial cells. LPA treatment accelerated wound closing and increased neoepithelial thickness. Cytological evaluation showed no evidence for a secondary inflammation-mediated injury, infection, or increased keloid formation. Whereas LPA caused only a modest dose-dependent increase in proliferating cells, a marked increase in the immigration of histiocyte-macrophage cells was observed as early as day 1. The peaks of several cytological features and immunohistological markers preceded those of the untreated side. Our data suggest that exogenously applied LPA in this model promotes healing and that macrophage-histiocytes are the primary LPA-responsive cells in vivo.
lipid; macrophage
This article has been cited by other articles:
|
|
 |
|
  J. Lattin, D. A. Zidar, K. Schroder, S. Kellie, D. A. Hume, and M. J. Sweet G-protein-coupled receptor expression, function, and signaling in macrophages J. Leukoc. Biol., July 1, 2007; 82(1): 16 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-P. Xu, J. Yin, and F.-S. X. Yu Lysophosphatidic Acid Promoting Corneal Epithelial Wound Healing by Transactivation of Epidermal Growth Factor Receptor Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 636 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Lloyd, Q. Tao, S. Lang, and C. Wylie Lysophosphatidic acid signaling controls cortical actin assembly and cytoarchitecture in Xenopus embryos Development, February 15, 2005; 132(4): 805 - 816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Lee, C. I. Lin, J.-J. Liao, Y.-W. Lee, H. Y. Yang, C.-Y. Lee, H.-Y. Hsu, and H. L. Wu Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi- and NF-{kappa}B-dependent mechanism Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1657 - C1666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tanaka, H. Tsutsui, K. Hirano, T. Koike, A. Tokumura, and K. Satouchi Quantitative analysis of lysophosphatidic acid by time-of-flight mass spectrometry using a phosphate-capture molecule J. Lipid Res., November 1, 2004; 45(11): 2145 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Jawhara and S. Mordon In Vivo Imaging of Bioluminescent Escherichia coli in a Cutaneous Wound Infection Model for Evaluation of an Antibiotic Therapy Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3436 - 3441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gruber, B. Kandler, C. Jindra, G. Watzak, and G. Watzek Dental Pulp Fibroblasts Contain Target Cells for Lysophosphatidic Acid J. Dent. Res., June 1, 2004; 83(6): 491 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sugiura, S. Nakane, S. Kishimoto, K. Waku, Y. Yoshioka, and A. Tokumura Lysophosphatidic acid, a growth factor-like lipid, in the saliva J. Lipid Res., December 1, 2002; 43(12): 2049 - 2055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-A. Wang, H. Du, J. H. Jaggar, D. N. Brindley, G. J. Tigyi, and M. A. Watsky Injury-elicited differential transcriptional regulation of phospholipid growth factor receptors in the cornea Am J Physiol Cell Physiol, December 1, 2002; 283(6): C1646 - C1654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Panther, M. Idzko, S. Corinti, D. Ferrari, Y. Herouy, M. Mockenhaupt, S. Dichmann, P. Gebicke-Haerter, F. Di Virgilio, G. Girolomoni, et al. The Influence of Lysophosphatidic Acid on the Functions of Human Dendritic Cells J. Immunol., October 15, 2002; 169(8): 4129 - 4135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. A. Contos, I. Ishii, N. Fukushima, M. A. Kingsbury, X. Ye, S. Kawamura, J. H. Brown, and J. Chun Characterization of lpa2 (Edg4) and lpa1/lpa2 (Edg2/Edg4) Lysophosphatidic Acid Receptor Knockout Mice: Signaling Deficits without Obvious Phenotypic Abnormality Attributable to lpa2 Mol. Cell. Biol., October 1, 2002; 22(19): 6921 - 6929. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tigyi Selective Ligands for Lysophosphatidic Acid Receptor Subtypes: Gaining Control over the Endothelial Differentiation Gene Family Mol. Pharmacol., December 1, 2001; 60(6): 1161 - 1164. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
